Company: VERA
Filing Date: 2025-01-13
Form Type: 8-K
Source: 0001193125-25-005010
Chunk: 1

Company: Vera Therapeutics, Inc.
Filing Date: 2025-01-13
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01      Financial Statements and Exhibits.  

(d) Exhibits.

  Exhibit      Description                                                                   
      No.                                                                                    
 ─────────────────────────────────────────────────────────────────────────────────────────────
     99.1      Slide presentation entitled “ J. P. Morgan Healthcare Conference”.            
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document).  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Vera Therapeutics, Inc.                                   
  By:                          /s/ Marshall Fordyce, M. D.  
                               Marshall Fordyce, M. D.      
                               Chief Executive Officer